Improved Flow Measurement Using Microbubble Contrast Agents and Disruption-Replenishment: Clinical Application to Tumour Monitoring

Ultrasound in Medicine and Biology

Volumn 37, Issue 8, 2011, Pages 1210-1221

  Hudson, John M ^a,b   Williams, Ross ^a,b   Lloyd, Brendan ^a,b   Atri, Mostafa ^c   Kim, Tae Kyoung ^c   Bjarnason, Georg ^a,d   Burns, Peter N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Blood flow; Disruption replenishment; Tumour monitoring; Ultrasound contrast agents

Indexed keywords

ANTIANGIOGENIC; BLOOD FLOW; BLOOD VOLUMES; CLINICAL APPLICATION; CLINICAL DATA; CLINICAL MEASUREMENTS; CONTRAST ENHANCED ULTRASOUND; CURVE FITTING MODEL; DISRUPTION-REPLENISHMENT; IN-VITRO; LOG-NORMAL; MICRO-BUBBLE; MICROBUBBLE CONTRAST AGENTS; MICROBUBBLE DISRUPTION; MICROBUBBLE FLOW; MULTIVESSEL; PERFUSION MODELS; PHANTOM STUDIES; RENAL CELL CARCINOMA; REPRODUCIBILITIES; SPATIAL AND TEMPORAL HETEROGENEITY; THREE MODELS; TUMOUR MICROVASCULATURE; ULTRASOUND CONTRAST AGENT;

BLOOD; CURVE FITTING; FLOWMETERS; MICROCIRCULATION; MONITORING; RATING; TUMORS; ULTRASONICS; VELOCITY MEASUREMENT; VOLUME MEASUREMENT;

FLOW MEASUREMENT;

PERFLUTREN; SUNITINIB;

ANTIANGIOGENIC THERAPY; ARTERY BLOOD FLOW; ARTICLE; B SCAN; BLOOD FLOW VELOCITY; BLOOD VOLUME; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED ULTRASOUND; HUMAN; IN VITRO STUDY; KIDNEY CARCINOMA; MICROBUBBLE; MICROVASCULATURE; MODEL; PATIENT MONITORING; PERFUSION; PHANTOM; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; ULTRASOUND;

BLOOD FLOW VELOCITY; BLOOD VOLUME; CARCINOMA, RENAL CELL; CONTRAST MEDIA; HEMORHEOLOGY; HUMANS; KIDNEY NEOPLASMS; MICROBUBBLES; MICROCIRCULATION; MODELS, THEORETICAL; NEOVASCULARIZATION, PATHOLOGIC; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS;

EID: 79959834747     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.04.001     Document Type: Article

References (25)

1. Arditi M., Frinking P.J., Zhou X., Rognin N.G. A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2006, 53:1118-1129.
2. Averkiou M.A., Lampaskis M., Kyriakopoulou K., Skarlos D., Klouvas G., Strouthos C., Leen E.L. Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. Ultrasound Med Biol 2010, 36:68-77.
3. Crow E.L., Shimizu K. Lognormal Distributions 1988, Marcel Dekker, Inc., New York.
4. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
5. Gauthier T.P., Averkiou M.A., Leen E.L. Perfusion quantification using dynamic contrast-enhanced ultrasound: The impact of dynamic range and gain on time-intensity curves. Ultrasonics 2011, 51:102-106.
6. Hudson J.M., Karshafian R., Burns P.N. Quantification of flow using ultrasound and microbubbles: A disruption replenishment model based on physical principles. Ultrasound Med Biol 2009, 35:2007-2020.
7. Karshafian R., Burns P., Henkelman M. Transit time kinetics in ordered and disordered vascular trees. Phys Med Biol 2003, 48:3225-3237.
8. Krix M., Kiessling F., Farhan N., Schmidt K., Hoffend J., Delorme S. A multivessel model describing replenishment kinetics of ultrasound contrast agent for quantification of tissue perfusion. Ultrasound Med Biol 2003, 29:1421-1430.
9. Krix M., Plathow C., Kiessling F., Herth F., Karcher A., Essig M., Schmitteckert H., Kauczor H., Delorme S. Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. Ultrasound Med Biol 2004, 30:1355-1363.
10. Lampaskis M., Averkiou M.A. Investigation of the relationship of nonlinear backscattered ultrasound intensity with microbubble concentration at low MI. Ultrasound Med Biol 2010, 36:306-312.
11. Lamuraglia M., Bridal S.L., Santin M., Izzi G., Rixe O., Paradiso A., Lucidarme O. Clinical relevance of contrast-enhanced ultrasound in monitoring antiangiogenic therapy of cancer: Current status and perspectives. Crit Rev Oncol Hematol 2010, 73:202-212.
12. Lassau N., Chami L., Benatsou B., Peronneau P., Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: A new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol Suppl 2007, 17:89-98.
13. Lassau N., Koscielny S., Albiges L., Chami L., Benatsou B., Chebil M., Roche A., Escudier B. Metastatic renal cell carcinoma treated with sunitinib: Early evaluation of treatment response using dynamic contrast-enhanced ultrasonography. Clin Cancer Res 2010, 16:1216-1225.
14. Lueck G, Hudson JM, Williams R, Sureshkumar A, Martel A, Burns PN. Combined image registration methods for parametric contrast imaging of tumour blood flow. In: 14th European Symposium Ultrasound Contrast Imaging, 2009.
15. Lindner J.R., Villanueva F.S., Dent J.M., Wei K., Sklenar J., Kaul S. Assessment of resting perfusion with myocardial contrast echocardiography: Theoretical and practical considerations. Am Heart J 2000, 139:231-240.
16. Lucidarme O., Franchi-Abella S., Correas J.M., Bridal S.L., Kurtisovski E., Berger G. Blood flow quantification with contrast-enhanced US: " Entrance in the section" phenomenon-phantom and rabbit study. Radiology 2003, 228:473-479.
17. Mancuso M.R., Davis R., Norberg S.M., O'Brien S., Sennino B., Nakahara T., Yao V.J., T Inai T., Brooks P., Freimark B. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006, 113:2610-2621.
18. Potdevin T.C., Fowlkes J.B., Moskalik A.P., Carson P.L. Analysis of refill curve shape in ultrasound contrast agent studies. Med Phys 2004, 31:623-632.
19. Qian H., Bassingthwaighte J.B. A class of flow bifurcation models with lognormal distribution and fractal dispersion. J Theor Biol 2000, 205:261-268.
20. Rim S., Leong-Poi H., Lindner J., Couture D., Ellegala D., Mason H., Durieux M., Kassel N., Kaul S. Quantification of cerebral perfusion with " real-time" contrast-enhanced ultrasound. Circulation 2001, 104:2582-2887.
21. Stride E., Tang M., Eckersley R.J. Physical phenomena affecting quantitative imaging of ultrasound contrast agents. Appl Acoust 2009, 70:1352-1362.
22. Tang T.X., Mari J.M., Wells P.N.T., Eckersley R.J. Attenuation correction in ultrasound contrast agent imaging: Elementary theory and preliminary experimental evaluation. Ultrasound Med Biol 2010, 34:1998-2008.
23. Veltmann C., Lohmaier S., Schlosser T., Shai S., Ehlgen A., Pohl C., Becher H., Tiemann K. On the design of a capillary flow phantom for the evaluation of ultrasound contrast agents at very low flow velocities. Ultrasound Med Biol 2002, 28:625-634.
24. Weber M., Krakowski-Roosen H., Delorme S., Renk H., Krix M., Millies J., Kinscherf R., Kunkele A., Kauczor H., Hildebrandt W. Relationship of skeletal muscle perfusion measured by contrast-enhanced ultrasonography to histologic microvascular density. J Ultrasound Med 2006, 25:583-591.
25. Wei K., Jayaweera A., Firoozan S., Linka A., Skyba D., Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97:473-483.